Guggenheim Capital’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27M | Sell |
11,922
-1,863
| -14% | -$198K | 0.01% | 799 |
|
|
2025
Q1 | $1.26M | Buy |
13,785
+2,732
| +25% | +$249K | 0.01% | 795 |
|
|
2024
Q4 | $1.26M | Sell |
11,053
-2,137
| -16% | -$244K | 0.01% | 812 |
|
|
2024
Q3 | $1.57M | Sell |
13,190
-9
| -0.1% | -$1.07K | 0.01% | 907 |
|
|
2024
Q2 | $1.06M | Sell |
13,199
-7,971
| -38% | -$641K | 0.01% | 1089 |
|
|
2024
Q1 | $1.95M | Buy |
21,170
+2,971
| +16% | +$274K | 0.01% | 889 |
|
|
2023
Q4 | $1.92M | Sell |
18,199
-853
| -4% | -$90K | 0.01% | 860 |
|
|
2023
Q3 | $2.07M | Sell |
19,052
-3,965
| -17% | -$431K | 0.02% | 799 |
|
|
2023
Q2 | $2.48M | Buy |
23,017
+6,489
| +39% | +$700K | 0.02% | 766 |
|
|
2023
Q1 | $2.06M | Buy |
16,528
+1,247
| +8% | +$155K | 0.02% | 834 |
|
|
2022
Q4 | $2.3M | Sell |
15,281
-2,328
| -13% | -$350K | 0.02% | 804 |
|
|
2022
Q3 | $2.38M | Sell |
17,609
-3,189
| -15% | -$430K | 0.02% | 772 |
|
|
2022
Q2 | $3.1M | Sell |
20,798
-3,473
| -14% | -$518K | 0.02% | 728 |
|
|
2022
Q1 | $4.14M | Buy |
24,271
+3,256
| +15% | +$555K | 0.02% | 721 |
|
|
2021
Q4 | $5.42M | Buy |
21,015
+6,294
| +43% | +$1.62M | 0.03% | 652 |
|
|
2021
Q3 | $4.02M | Sell |
14,721
-1,944
| -12% | -$531K | 0.02% | 744 |
|
|
2021
Q2 | $3.73M | Sell |
16,665
-15,628
| -48% | -$3.5M | 0.02% | 792 |
|
|
2021
Q1 | $3.53M | Sell |
32,293
-2,502
| -7% | -$273K | 0.02% | 772 |
|
|
2020
Q4 | $2.84M | Buy |
+34,795
| New | +$2.84M | 0.02% | 813 |
|